Buchumschlag

Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder†

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Tibor Szarvas, Henning Reis
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	The Journal of Pathology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Molecular subtype concordance and metastatic patterns in muscle‐invasive bladder cancer
von: Csilla Olah, et al.
Veröffentlicht: (2026)

Use of UV mutational signatures to distinguish between cutaneous and pulmonary primary squamous cell carcinoma
von: Jeffrey S. Ross, et al.
Veröffentlicht: (2024)

Deep learning‐based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images
von: Jun Hyeong Park, et al.
Veröffentlicht: (2024)

The spatial landscape of T cells in the microenvironment of stage III lung adenocarcinoma
von: Ziqing Zeng, et al.
Veröffentlicht: (2024)

TP53 mutations in urothelial carcinoma: not all one and the same†
von: Alexis R Barr, et al.
Veröffentlicht: (2024)

DNA ‐hypermethylated human gastric cancer circumvents apoptosis in the absence of TP53 mutation
von: Yasunobu Mano, et al.
Veröffentlicht: (2025)

Involvement of KEAP1/NRF2 pathway in non‐BRAF mutated squamous cell carcinoma of the thyroid
von: Elin Schoultz, et al.
Veröffentlicht: (2025)

Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasms
von: Lucas‐Alexander Schulte, et al.
Veröffentlicht: (2025)

Clinicopathological and molecular spectrum of patients with germline SUFU mutations: A case series
von: Mashiro van Dal, et al.
Veröffentlicht: (2024)

Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors
von: Michael Menzel, et al.
Veröffentlicht: (2024)

Clinicopathological characteristics of patients with inoperable non‐small cell lung cancer harboring circulating NRF2 pathway mutations
von: Jouni Härkönen, et al.
Veröffentlicht: (2026)

Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
von: Csilla Olah, et al.
Veröffentlicht: (2025)

TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1/PD‐L1 blockade response in urothelial carcinoma
von: Kaifeng Jin, et al.
Veröffentlicht: (2024)

Cutaneous Rosai–Dorfman disease with MAP2K1 mutation, initially mimicking an infection with parasitized histiocytes
von: Joseph Gillam, et al.
Veröffentlicht: (2024)

Clinicopathological characteristics and diagnostic accuracy of BRAF mutations in ameloblastoma: A Bayesian network analysis
von: Ao‐Bo Zhang, et al.
Veröffentlicht: (2024)

Microfluidics‐based EGFR mutation detection and its implication in the resource‐limited clinical setting
von: Pradnya Joshi, et al.
Veröffentlicht: (2024)

Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivoLMNA::NTRK1‐rearranged soft‐tissue sarcoma cell model
von: Yanjiang Chen, et al.
Veröffentlicht: (2024)

The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK / ERK mutations and clonal evolution
von: DuJiang Yang, et al.
Veröffentlicht: (2025)

Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome‐wide mutation analysis
von: Lihong Li, et al.
Veröffentlicht: (2025)

From morphology to methylome: epigenetic studies of Müllerian mesonephric‐like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma†
von: Lawrence H Lin, et al.
Veröffentlicht: (2024)

A dominant negative Kcnd3 F227del mutation in mice causes spinocerebellar ataxia type 22 ( SCA22 ) by impairing ER and Golgi functioning
von: Hao‐Chih Hung, et al.
Veröffentlicht: (2024)

PIK3CA mutation status in apocrine carcinoma arising in apocrine gland hyperplasia/apocrine nevus: A study of four cases
von: Keisuke Goto, et al.
Veröffentlicht: (2024)

Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis
von: Dominik Nann, et al.
Veröffentlicht: (2025)

Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer
von: Sangkyou Lee, et al.
Veröffentlicht: (2025)

Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom‐up approach
von: Marc Hilmi, et al.
Veröffentlicht: (2025)

It was not possible to detect BRAF V600E mutation in circulating cell‐free DNA from patients with ameloblastoma: A diagnostic accuracy study
von: Allan Vinícius Martins‐de‐Barros, et al.
Veröffentlicht: (2024)

Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing study
von: Yongsheng Huang, et al.
Veröffentlicht: (2024)

Authors' reply: Re: Yang et al . The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK / ERK mutations and clonal evolution
von: Dominik Nann, et al.
Veröffentlicht: (2025)

LINE ‐1 hypomethylation characterizes the inflammatory response in coeliac disease associated‐intestinal mucosa and small bowel adenocarcinomas
von: Laura Libera, et al.
Veröffentlicht: (2024)

Multi‐omics analyses reveal distinct molecular characteristics and transformation mechanisms of stage I–III micropapillary lung adenocarcinoma
von: Yang Qu, et al.
Veröffentlicht: (2025)

RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors
von: Marialetizia Motta, et al.
Veröffentlicht: (2024)

Alternative driver pathways in peripheral nerve sheath tumors – including DICER1 and/or KRAS alterations
von: Hsin‐Yi Chang, et al.
Veröffentlicht: (2025)

Comparative transcriptomics of salivary basal cell adenoma and adenocarcinoma sustain linear neoplastic evolution and intertumor heterogeneity: classification and biological implications
von: Yoshitsugu Mitani, et al.
Veröffentlicht: (2025)

Genetic landscape of non‐ UV ‐induced cutaneous squamous cell carcinomas
von: Carmen Al Youssef, et al.
Veröffentlicht: (2025)

Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusions
von: Joanna Cyrta, et al.
Veröffentlicht: (2024)

Autopsy case of linear nevus sebaceous syndrome with KRAS (G12D) mutation
von: Akira Ohishi, et al.
Veröffentlicht: (2024)

PAX2 is regulated by estrogen/progesterone through promoter methylation in endometrioid adenocarcinoma and has an important role in carcinogenesis via the AKT / mTOR signaling pathway
von: Hui Chen, et al.
Veröffentlicht: (2024)

Prognostic significance of beta‐adrenergic receptor expression in oesophageal adenocarcinoma
von: Talita Oliveira, et al.
Veröffentlicht: (2026)

Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions
von: Joachim T Siaw, et al.
Veröffentlicht: (2025)

Exploring the molecular landscape of cutaneous mixed tumors characterized by TRPS1 :: PLAG1 gene fusion
von: Ziyad Alsugair, et al.
Veröffentlicht: (2024)